[62]
Connolly PJ, Lu T. Benzamide derivatives is useful as FASN inhibitors for the treatment of cancer. United States Patent Application Publication; US 20160009688A12016.,
[63]
Connolly PJ, Lu T. Imidazolin-5-one derivatives useful as FASN inhibitors for the treatment of cancer. United States Patent Application Publication; US97188132017.,
[64]
Tsaklakidis C, Staehle W, Leuthner B, Fuchss T. 1,3-disubstituted cyclopentane derivatives. United States Patent Application Publication; US20160176824A1, 2016.
[65]
Tsaklakidis C, Staehle W, Leuthner B. 3-substituted cyclopentylamine derivatives. United States Patent Application Publication; US20160200714A1, 2016.
[66]
Tsaklakidis C, Staehle W, Leuthner B, Czodrowski P. 3-Aminocyclopentane carboxamide derivatives. United States Patent Application Publication; US20160264517A12016.,
[67]
Staehle W, Tsaklakidis C, Friese-Hamim M, Leuthner B, Wienke D. Piperazine derivatives as fasn inhibitors. United States Patent Application Publication; US20160280655A12016.,
[68]
Tsaklakidis C, Staehle W, Leuthner B, Czodrowski P, Fuchss T. 1,3-Diaminocyclopentane carboxamide derivatives. United States Patent Application Publication; US9670142B22017.,
[69]
Becknell CN, Dandu Reddy R, Dorsey DB, et al. 1,4-substituted piperidine derivatives. WO2016205633, 2016.
[70]
Hudkins RL, Whitman DB, Zificsak CA, Zulli AL, Mcwherter M. Spiropiperidine derivatives. Patent WO2018112204A1 2018.
[71]
Cosford DPN, Smith J, Ardecky JR, Zou J, Mattman M, Teriete P. Small molecule fatty acid synthase inhibitors. Patent US20170066731A12017.,
[72]
Bahadoor A, Castro CA, Chan KL, et al. Tetrazolones as inhibitors of fatty acid synthase. Patent US20170119734, 2017.
[73]
Kwiek JJ, Haystead T, Hughes P, Alwarawrah Y. Fatty acid synthase inhibitors. Patent WO20171848442017,
[74]
Becknell CN, Dandu Reddy R, Dorsey DB, Gotchev BD, Hudkins LR, Weinberg L. 1,4-Substituted piperidine derivatives. Patent US201901529132019.,
[75]
Becknell CN, Dandu Reddy R, Dorsey DB, et al. Substituted 4-benzyl and 4-benzoyl piperidine derivatives. Patent US10919875, 2021.
[76]
Chen Y, Qu H, Tang C, et al. Fatty acid synthase inhibitor and application thereof United States Patent US202100460272021.,
[77]
Bair KW, Lancia DR, Li H. Novel compounds and compositions for inhibition of FASN United States Patent US201600021882016.,
[78]
Millan DS, Lu W. Methods of using FASN inhibitors Patent WO20171896132017.,
[79]
Martin MW, Zablocki MM, Mente S, Dinsmore C, Wang Z, Zheng X. Inhibiting fatty acid synthase (FASN). Patent US202100245082021.,
[80]
Oslob JD, Mcdowell RS, Johnson R, et al. Heterocyclic modulators of lipid synthesis Patent US20160311803, 2016.
[81]
Heuer TS, Oslob JD, McDowell RS, et al. Heterocyclic modulators of lipid synthesis and combinations thereof Patent US201603389982016.,
[82]
Wagman AS, Johnson RJ, Zaharia CA, et al. Heterocyclic modulators of lipid synthesis for use against cancer and viral infections Patent US201603261412016.,
[83]
Buckley DI, Duke G, Wagman AS, Evanchik M. McDowell R S. Heterocyclic modulators of lipid synthesis. Patent US20190269694A1, 2019.
[84]
Buckley DI, Duke G, Wagman AS, Evanchik M, Mcdowell RS. Heterocyclic modulators of lipid synthesis Patent WO20180899042018.,